Skip to main content
. 2016 Sep 19;11(9):e0162244. doi: 10.1371/journal.pone.0162244

Fig 6. In silico model of the dynamic regulation of mir-155 targetome during experimental in vivo human RV infection.

Fig 6

(A) Early downregulation (8hr) of validated hsa-miR-155 targets implicated in host immune response followed by upregulation at 48h (B). IPA network analysis identified overrepresented targets for hsa-mir-155 at 8hr after RV infection.